Hosted on MSN20h
TD Cowen Downgrades Science Applications International (SAIC)
Fintel reports that on January 8, 2025, TD Cowen downgraded their outlook for Science Applications International ...
Hosted on MSN20h
TD Cowen Downgrades Kimberly-Clark (KMB)
Fintel reports that on January 8, 2025, TD Cowen downgraded their outlook for Kimberly-Clark (NYSE:KMB) from Buy to Hold.
New drugs mean higher prices — and a big year for Big Pharma
The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug Pricing survey.
bovnews10h
Marathon Petroleum Corp (MPC)’s Stock Surge: What You Need to Know
TD Cowen has recently reiterated Marathon Petroleum Corp (MPC) stock to Buy rating, as announced on December 10, 2024, according to Finviz. Earlier, on November 6, 2024, TD Cowen had reiterated the ...
FiercePharma14h
With BIOSECURE in limbo, should BeiGene or Legend sell itself in 2025? Analysts weigh in
When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...
TD Cowen's investment themes for 2025: Spotting opportunities and risks
Lisa Thomas, Managing Director and Deputy Head of Global Research at TD Cowen, discusses some of the key findings of a new TD ...